 "Coronavirus, vaccine, covid, drugs, clinical trials")
NEW DELHI (Reuters) - The Serum Institute of India, the world's biggest vaccine maker, will start stockpiling millions of doses of the Novavax coronavirus vaccine candidate starting around April, CEO Adar Poonawalla told the Reuters Next conference on Thursday.
"Upwards of 40-50 million doses per month is what we are trying to stockpile starting from April," he said.
For more coverage from the Reuters Next conference please click here or http://www.reuters.com/business/reuters-next
(Reporting by Euan Rocha; editing by Jason Neely)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
